Paula Jiménez‐Fonseca

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Jianming Xu, Ken Kato, Eric Raymond et al. · The Lancet Oncology · 2023 · 291 citations

Medicine, Oncology, Pharmacology +12

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 161 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

SEOM clinical guidelines on nutrition in cancer patients (2018)

R. de las Peñas, Margarita Majem, Javier Pérez-Altozano et al. · Clinical & Translational Oncology · 2019 · 118 citations · Full text

Agriculture, Nutrition, Oncology +17

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

Jaume Capdevila, Nicola Fazio, Carlos López et al. · Journal of Clinical Oncology · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +16

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

Barbara Nuñez-Valdovinos, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al. · The Oncologist · 2018 · 92 citations · Full text

Medicine, Oncology, Pathology +17